Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates

British Journal of Cancer

Volumn 75, Issue 1, 1997, Pages 54-61

  Schmidt Erfurth, U ^a,b   Diddens, H ^a,b   Birngruber, R ^a,b   Hasan, T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MEDICAL LASER CENTER LÜBECK   (Germany)

Author keywords

Chlorin; Neovascularization; Ocular; Photochemistry

Indexed keywords

CHLORIN E6; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; COVALENT BOND; DRUG CONJUGATION; DRUG TARGETING; DRUG UPTAKE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; RETINOBLASTOMA; SPECTROFLUOROMETRY;

EID: 0031012325     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.9     Document Type: Article

References (64)

1. Abramson DH, Jeeb B and Ellsworth RM (1981) External beam radiation for retinoblastoma. Bull NY Acad Med 57: 787-803.
2. Allison BA, Pritchard PH, Richter AM and Levy JG (1990) The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution. Photochem Photobiol 52:501-507
3. Allison BA, Pritchard, PH and Levy JG (1994) Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. Br J Cancer 69: 833-839
4. Anderson RGW, Vasile E, Mello RJ, Brown MS and Goldstein JL (1978) Immunocytochemical visualization of coated pits and vesicles in human fibroblasts: relation to low-density lipoprotein receptor distribution. Cell 15: 919-933
5. 6-conjugated microspheres. Proc Natl Acad Sci USA 88: 1580-1584
6. 6 in human bladder carcinoma cells. J Urol 51: 4410-4414
7. 6 in the pholodynamic therapy of human bladder carcinoma cells. J Urol 146: 1654-1658
8. Brown MS and Goldstein JL (1975) Regulation of the activity of the low density lipoprotein receptor in human fibroblasts. Cell 6: 307-316
9. Bruce RA, JR (1987) Evaluation of hematoporphyrin photoradiation therapy techniques in the treatment of intraocular tumours. Photochem Photobiol 46: 919-923
10. Dougherty, TJ (1987) Photosensitizers: therapy and detection of malignant tumours. Photochem Photobiol 45: 879-889
11. Dougherty TJ (1989) Photodynamic therapy - new approaches (review). Semin Surg Oncol 5: 6-16
12. Endenmann G, Stanton LW, Madden KS, Bryant CM, White RT and Prolter AA (1993) CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811-11816
13. Gal D, Mcdonald PC, Porter JC and Simpson ER (1981) Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism. Int J Cancer 28: 315-319
14. Goff BA, Bamberg M and Hasan T (1991) Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res 51: 4762-4767
15. Goff BA, Hermanto U, Rumbaugh J, Blake J, Bamberg M and Hasan. T (1994) Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br J Cancer 70: 474-480
16. Gomer CJ (1991) Preclinical examination of first and second generation photosensitizers used in photodynamic therapy. Photochem Photobiol 34: 1093-1107
17. Haberland ME, Olch CI, and Folgelman AM (1984) Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J Biol Chem 259: 11305-11311
18. Hamblin MR and Newman EL (1994) Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. J Photochem Photobiol B 26: 147-157
19. Hasan T (1992) Photosensitizer delivery mediated by macromolecular carrier systems. In Photodynamic Therapy: Basic Principle and Clinical Applications. Henderson B and Dougherty T (eds). Marcel Dekker, 187-200
20. Hasan T and Parrish JA (1996) Photodynamic therapy of cancer. In Cancer Medicine 4th edn. Holland JF (ed.). Williams and Wilkins Vol 1, Chpt 50, 739-751
21. Henderson BW and Dougherty TJ (1992) How does PDT work? Photochem Photobiol 55: 145-157
22. Henderson BW and Fingar VJ (1987) Relationship of tumour hypoxia and response to photodynamic treatment in an experimental mouse tumour. Cancer Res 47: 3110-3114
23. Itakura H, Matsumoto A, Asaoka H and Kodama T (1993) Structure and function of the scavenger receptor. Nippon Rinsho 51: 1083-1091
24. Jiang FN, Liu DJ, Neyndorff H, Chester M, Jiang S and Levy JG (1991) Photodynamic killing of human squamous cell carcinoma cells using a monoclonal antibody-photosensitizer conjugate. J Natl Cancer Inst 83: 1218-1225
25. Jori G (1989) In vivo transport and pharmacokinetic behaviour of tumour photosensitizers. In Photosensitizing Compounds: their Chemistry. Biology and Clinical Use. Ciba foundation Symposium 146 John Wiley and Sons: Chichester, UK.
26. Jori G (1990) Factors controlling the selectivity and efficiency of tumour damage of photodynamic therapy. Lasers Med Sci 5: 115-120
27. Jori G, Beltramini M, Reddi E, Pagnan A, Tomio L and Tsanov T (1984) Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. Cancer Lett 24: 291-297
28. Jori G and Reddi E (1990) Strategies for tumour targeting by photodynamic sensitizers. In Photodynamic Therapy of Neoplastic Disease. Kessel D (ed.). CRC Press: Boca Raton, EL. 117-130
29. Khoo JC, Miller E, Mcloughlin P and Steinberg D (1988) Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis 8: 348-358
30. Larson E, Howlett B and Jagendorf A (1986) Artificial reductant enhancement of the Lowry method for protein determination. Anal Biochem 155: 243-248
31. Lisanti MP, Scherer PE, Vidugieriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF and Sargiacomo M (1994) Characterisation of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol. 126: 111-126
32. Maziere JC, Santus R, Morliere P, Reyftmann JP, Candide C, Mora L, Salmon S, Maziere C, Gatt S and Dubertret L (1990) Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins (review). J Photochem Photobiol 6: 61-68
33. Mew D, Wat CK, Towers GHN and Levy JG (1983) Photoimmunotherapy: treatment of animal tumours with tumour-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol 130: 1473-1477
34. Moan J, Peng Q, Evensen JF, Berg K, Western A and Remington C (1987) Photosensitizing efficiencies tumour and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol 46: 713-721
35. Mosley ST, Goldstein JL, Brown MS, Falck JR and Anderson RGW (1981) Targeted killing of cultured cells by receptor-dependent photosensitization. Proc Nati Acad Sci USA 78: 5217-5721
36. Murphree AL, Cote M and Gomer CJ (1987) The evolution of photodynamic therapy techniques in the treatment of intraocular tumours. Photochem Photobiol 46: 919-923
37. Naito M, Suzuki H, Mori T, Matsumoto A, Kodama T and Takahashi K (1992) Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol 141: 591-599
38. 6 conjugates. Proc Natl Acad Sci USA 83: 8744-8748
39. Parthasarathy S (1991) Novel atherogenic, oxidative modification of low-density lipoprotein. Diabetes Metab Rev 7: 163-171
40. Roberts WG and Hasan T (1992) Role of neovasculature and vascular permeability on the tumour retention of photodynamic agents. Cancer Res 52: 924-930
41. Roberts WG and Hasan T (1993) tumour-secreted vascular permeability factor influences photosensitizer uptake. Cancer Res 53: 1-5
42. Rudel U, Lee JA, Morris MD and Fells JM (1974) Characterization of plasma lipoproteins separated and purified by agarose-column chromatography. Biochem J 139: 89-95
43. Rudling MJ, Angelin B, Peterson CO and Collins VP (1990) Low density lipoprotein receptor activity in human intracranial tumours and its relation to the cholesterol requirement. Cancer Res 50: 483-487
44. Rutledge JC, Curry F-RE, Lenoc JF and Davis PA (1990) Low density lipoprotein transport across a microvascular endothelial barrier after permeability is increased. Circ Res 66: 486-494
45. Sargent JM and Taylor CG (1989) Appraisal of the MII assay as a rapid test of chemosensitivity in acute haircell leukemia. Br J Cancer 60: 206-210
46. Schmidt-Erfurth U, Bauman W, Gragoudas E, Flotte TJ, Michaud NA, Birngruber R and Hasan T (1994) Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology 101: 89-99
47. Schmidt-Erfurth U, Flotte TJ, Gragoudas ES, Schomacker K, Birngruber R and Hasan T (1995a) Benzoporphyrin-Lipoprotein mediated photodestruction of intraocular tumours. Exp Eye Res 62: (in press)
48. Schmidt-Erfurth U, Hasan T, Schomacker K, Flotte T and Birngruber R (1995b) In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med 17: 178-188
49. Sery T (1979) Photodynamic killing of retinoblastoma cells with hematoporphyrin and light. Cancer Res 39, 90-100
50. Sery TW, Shields JA, Augsburger JJ and Shah HG (1987) Photodynamic therapy of human ocular cancer. Ophthal Surg 18: 413-418
51. Shields CL, Shield JA, De Potter P, Muelli S, Hernandes C, Brady LW, and Cater JR, (1993) Plaque radiotherapy in the management of retinoblastoma. Ophthalmology 100: 216-224
52. Simionescu, N and Simionescu M (1991) Cellular interactions of lipoproteins with the vascular endothelium: endocytosis and transcytosis. Targeted Diagn Ther 5: 45-95
53. Suits AG, Chait A, Aviram M and Heinecke JW (1989) Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. Proc Natl Acad Sci USA 86: 2713-2717
54. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG and Orekhov AN (1989) Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem Biophys Res Commun 163: 489-494
55. Tse DT, Dutton JJ and Weingeist TA (1989) Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. Arch Ophthalmol 102: 833-838
56. Van Hillegersberg R, Kort WJ and Wilson JH (1994) Current status of photodynamic therapy in oncology (Review). Drugs 48: 510-527
57. Vasile E, Simionescu M and Simionescu N (1983) Visualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situ. J Cell Biol 96: 1677-1689
58. Vitols S (1991) Uptake of low-density lipoprotein by malignant cells - possible therapeutic applications. Cancer Cells 3, 488-495
59. Vitols S, Gahrton G, Bjorkhol M and Peterson C (1985) Hypocholesterolemia in malignancy due to elevated LDL receptor activity in tumour cells. Lancet 2: 1150-1154
60. Vlodavsky I, Fielding PE, Fielding CJ and Gospodarowicz D (1978) Role of contact inhibition in the regulation of receptor-mediated uptake of low density lipoprotein in cultured vascular endothelial cells. Proc Natl Acad Sci USA 75: 356-360
61. Voyta JC, Via DP, Butterfield CE and Zetter BR (1984) Identification and isolation of endothelial cells based on their increased uptake of aetylated low-density lipoprotein. J Cell Biol 99: 2034-2040
62. Weishaupt UR, Gomer CJ and Dougherty TJ (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumour. Cancer Res 36: 2326-2329
63. Winther J (1989) Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vivo to in vitro colony forming assay. Br J Cancer 59: 869-872
64. Zhou C, Milanesi C and Jori G (1988) An ultrastructural comparative evaluation of tumours photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins. Photochem Photobiol 48: 487-492